Old Web
English
Sign In
Acemap
>
Paper
>
Gemtuzumab ozogamicin in the treatment of critically ill patients with refractory acute myeloid leukemia
Gemtuzumab ozogamicin in the treatment of critically ill patients with refractory acute myeloid leukemia
2019
Daniil Zaytsev
Larisa Girshova
Vladimir Ivanov
Irina Budaeva
D. Motorin
Renat Badaev
Konstantin Bogdanov
Julia Mirolubova
Tatjana Nikulina
Tamara Chitanava
Julia Alexeeva
A Zaritskey
Keywords:
Gemtuzumab ozogamicin
Myeloid leukemia
Refractory
Biology
Cancer research
critically ill
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]